Trace Neuroscience

Trace Neuroscience is a biopharmaceutical company developing novel genomic therapies to restore UNC13A protein function in neurodegenerative diseases. Their lead program focuses on an antisense oligonucleotide for amyotrophic lateral sclerosis (ALS) to improve muscle function. The company aims to expand the promise of genomic medicine for individuals with neurodegenerative diseases.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: $101M

Date: 12-Nov-2024

Investors: Third Rock Ventures, Atlas Venture, GV, RA Capital Management

Markets: Biopharmaceutical, Genomic Medicine, Neurodegenerative Diseases, Biotechnology, Health Care, Life Science

HQ: South San Francisco, California, United States

Founded: 2024

Website: https://www.traceneuro.com

LinkedIn: https://www.linkedin.com/company/traceneuroscience

Twitter: https://x.com/TraceNeuro

Instagram: